ProfileGDS5678 / 1442562_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 8% 8% 8% 9% 8% 11% 11% 13% 8% 8% 9% 10% 9% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.216228
GSM967853U87-EV human glioblastoma xenograft - Control 22.200598
GSM967854U87-EV human glioblastoma xenograft - Control 32.192578
GSM967855U87-EV human glioblastoma xenograft - Control 42.170719
GSM967856U87-EV human glioblastoma xenograft - Control 52.15878
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3343311
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.2856611
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3015213
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.176888
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.193898
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.194139
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2219410
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.207979
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.189118